ClinicalTrials.Veeva

Menu

Early Screening and Identification for Panvascular Diseases

Capital Medical University logo

Capital Medical University

Status

Enrolling

Conditions

Panvascular Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT05485870
2021YFC2500502

Details and patient eligibility

About

Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis.

Full description

Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis by a multi-omics study.

Enrollment

1,000 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    1. Patients with panvascular diseases; 2. Patients or guardians who agreed to join the study; 3. Patients who can complete the relevant examinations involved in this study;

Exclusion criteria

  • patients with coagulation dysfunction.

Trial design

1,000 participants in 2 patient groups

Panvascular disease group
Description:
patients with panvascular diseases
Healthy controls
Description:
Healthy controls

Trial contacts and locations

1

Loading...

Central trial contact

Peicong Ge, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems